Phesi Publishes Latest Update on Impact of the War on Clinical Development in Ukraine
Phesi has published its latest update on the significant impact of the war in Ukraine on clinical development in the region. Phesi’s analysis of recruiting investigator sites (those actively enrolling patients) finds that since the beginning of 2022 to the Oct. 1, 2022, the number of recruiting sites has fallen from 1,814 to 940 (48%) in Ukraine, yet the other half are continuing to recruit. In Russia, recruiting sites have fallen from 3,412 to 1,638 (52%) and in Belarus from 84 to 33 (55%).
Read more from this update here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
